With its easy-to-digest reviews on important advances in world literature, Current Opinion in Oncology offers expert evaluation on a wide range of topics from sixteen key disciplines including sarcomas, cancer biology, melanoma and endocrine tumors. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. This is supplemented by annotated references detailing the merits of the most important papers.
《肿瘤学最新观点》以其易于消化的世界文献重要进展综述，提供了来自16个关键学科的广泛主题的专家评估，包括肉瘤、癌症生物学、黑色素瘤和内分泌肿瘤。每两个月出版一次，每期都详细介绍前一年在这些领域取得的最相关进展。这是补充的注释参考详细的优点，最重要的文件。
Contemporary treatments in prostate cancer focal therapy
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000515
Current role of primary surgical treatment in patients with head and neck squamous cell carcinoma
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000531
New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000535
Immunotherapy in patients with early stage resectable nonsmall cell lung cancer
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000497
Targeting the androgen receptor and overcoming resistance in prostate cancer
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000520
Molecular genetics of head and neck squamous cell carcinoma
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000536
Chordoma: update on disease, epidemiology, biology and medical therapies
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000502
Adjuvant treatment for endometrial cancer.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000558
Adrenal tumours: open surgery versus minimally invasive surgery.
来源期刊：Current opinion in oncologyDOI：10.1097/cco.0000000000000594
Use of noninvasive imaging in the management of skin cancer.
来源期刊：Current opinion in oncologyDOI：10.1097/cco.0000000000000611
Targeting the interplay between metabolism and epigenetics in cancer
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000501
Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000607
p53, stem cell biology and childhood blastomas
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000504
The microenvironment in myeloma.
来源期刊：Current opinion in oncologyDOI：10.1097/cco.0000000000000615
Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000577
Malignant pheochromocytoma and paraganglioma: management options.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000589
T-cell receptor and chimeric antigen receptor in solid cancers: current landscape, preclinical data and insight into future developments.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000562
Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000598
The tumor microenvironment in renal cell cancer
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000512
PET imaging in renal cancer
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000518
Neurological malignancies in neurofibromatosis type 1.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000576
Impact of ovarian function suppression in premenopausal women with estrogen receptor-positive early breast cancer
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000491
Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000533
Checkpoints inhibitors in the (neo)adjuvant setting of solid tumors: lessons learnt and perspectives.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000565
Angiogenesis inhibition in non-small cell lung cancer: a critical appraisal, basic concepts and updates from American Society for Clinical Oncology 2019.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000591
Window of Opportunity trials for biomarker discovery in breast cancer.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000583
Single-cell sequencing in hematology.
来源期刊：Current opinion in oncologyDOI：10.1097/cco.0000000000000613
Novel molecular targets for the treatment of lung cancer.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000590
New perspectives in Merkel cell carcinoma
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000508
The emergence of long-term survivors in recurrent and metastatic squamous cell head and neck cancer
来源期刊：Current Opinion in OncologyDOI：10.1097/CCO.0000000000000530
Advanced cutaneous squamous cell carcinoma: how is it defined and what new therapeutic approaches are available?
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000566
Management of leptomeningeal carcinomatosis and challenges of trial design.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000574
Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000592
Circulating biomarkers for the detection of tumor recurrence in the postsurgical follow-up of differentiated thyroid carcinoma.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000588
Immunotherapy of heterogenous sarcomas: questions and strategies.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000548
Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000557
Targeted therapies in melanoma beyond BRAF: targeting NRAS-mutated and KIT-mutated melanoma.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000606
Follicular lymphomas in vulnerable/older patients.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000555
Molecular prediction of metastasis in cutaneous squamous cell carcinoma.
来源期刊：Current opinion in oncologyDOI：10.1097/cco.0000000000000609
Targeting BRAF and MEK inhibitors in melanoma in the metastatic, neoadjuvant and adjuvant setting.
来源期刊：Current opinion in oncologyDOI：10.1097/cco.0000000000000614
Update on transarterial approaches to locoregional treatment in hepatocellular carcinoma.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000539
Approaches for vulnerable and frail older patients with diffuse large B-cell lymphomas.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000559
Mantle cell lymphoma in patients not eligible for autologous stem cell transplantation.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000556
Integrated treatment of brain metastases.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000573
Multicultural approaches of cancer pain.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000547
How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000563
Thymic malignancies: emerging systemic therapies.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000564
Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer.
来源期刊：Current opinion in oncologyDOI：10.1097/cco.0000000000000570
Palliative care in glioma management.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000584
Role of dose-dense chemotherapy in high-risk early breast cancer.
来源期刊：Current opinion in oncologyDOI：10.1097/CCO.0000000000000571
